Bayer says had productive meeting with Trump over Monsanto deal

FRANKFURT, Jan 12 (Reuters) - German drugs and pesticides

maker Bayer, which will need regulatory approval for

its $66 billion deal to buy U.S. seeds giant Monsanto,

said company chief executives had...

Read more